Radiotherapy is the most important adjuvant treatment for glioma; however, radioresistance is the major cause for inevitable recurrence and poor survival of glioma patients. Thus, this study aims to investigate the effect of astrocyte elevated gene-1 (AEG-1) on the radiosensitivity of glioma cells. Immunohistochemistry assay found that AEG-1 was generally overexpressed in glioma tissues and was correlated with poor clinicopathological features of glioma patients. AEG-1 knockdown inhibited proliferation of glioma cells. And γ-H2AX foci assay, colony formation assay, and flow cytometry analysis demonstrated that AEG-1 depletion enhanced radiosensitivity and promoted apoptosis as well as cell cycle arrest in G2 phase of glioma cells treated by ionizing radiation. Moreover, replication factor C5 (RFC5) was screened as the target of AEG-1 by using Affymetrix human gene expression array, and RFC5 expression was downregulated in AEG-1 knockdown glioma cells. Mechanistically, AEG-1 knockdown impaired homologous recombination repair activity induced by radiation through inhibiting RFC5 expression. Furthermore, the Kaplan–Meier analysis and multivariate Cox regression analysis indicated that high levels of AEG-1 and RFC5 were related to poor prognosis of glioma patients treated with radiotherapy. Taken together, our findings indicate that AEG-1 may serve as a reliable radiosensitizing target for glioma radiotherapy.
Get full access to this article
View all access options for this article.
References
1.
AghiM.K., NahedB.V., SloanA.E., RykenT.C., KalkanisS.N., and OlsonJ.J. (2015). The role of surgery in the management of patients with diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol, 125, 503–530.
2.
BerthelE., ForayN., and FerlazzoM.L. (2019). What does the history of research on the repair of dna double-strand breaks tell us?—a comprehensive review of human radiosensitivity. Int J Mol Sci, 20, 5339–5353.
3.
CabreraA.R., KirkpatrickJ.P., FiveashJ.B., ShihH.A., KoayE.J., LutzS., et al. (2016). Radiation therapy for glioblastoma: executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol, 6, 217–225.
4.
ChenJ., JiaY., JiaZ.H., ZhuY., and JinY.M. (2018). Silencing the expression of MTDH increases the radiation sensitivity of SKOV3 ovarian cancer cells and reduces their proliferation and metastasis. Int J Oncol, 53, 2180–2190.
5.
ChoY.H., LeeS.H., LeeS.J., KimH.N., and KohJ.Y. (2020). A role of metallothionein-3 in radiation-induced autophagy in glioma cells. Sci Rep, 10, 2015–2026.
6.
DavisM.E. (2018). Epidemiology and overview of gliomas. Semin Oncol Nursing, 34, 420–429.
7.
DhimanG., SrivastavaN., GoyalM., RakhaE., Lothion-RoyJ., MonganN.P., et al. (2019). Metadherin: a therapeutic target in multiple cancers. Front Oncol, 9, 349–357.
8.
DingQ., ChenY., DongS., XuX., LiuJ., SongP., et al. (2018). Astrocyte elevated gene-1 is overexpressed in non-small-cell lung cancer and associated with increased tumour angiogenesis. Interactive Cardiovasc Thorac Surg, 26, 395–401.
9.
DingZ., ZhangZ., JinX., ChenP., LvF., LiuD., et al. (2019). Interaction with AEG-1 and MDM2 is associated with glioma development and progression and correlates with poor prognosis. Cell Cycle, 18, 143–155.
10.
El-AshmawyN.E., El-ZamaranyE.A., KhedrE.G., and Abo-SaifM.A. (2019). Activation of EMT in colorectal cancer by MTDH/NF-κB p65 pathway. Mol Cell Biochem, 457, 83–91.
11.
Gandia-GonzalezM.L., CerdanS., BarriosL., Lopez-LarrubiaP., FeijooP.G., PalpanA.Jr., et al. (2019). Assessment of overall survival in glioma patients as predicted by metabolomic criteria. Front Oncol, 9, 328–339.
12.
GnosaS., ZhangH., BrodinV.P., CarstensenJ., AdellG., and SunX.F. (2014). AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial. Br J Cancer, 111, 166–173.
13.
GotoY., KoyasuS., KobayashiM., and HaradaH. (2017). The emerging roles of the ubiquitination/deubiquitination system in tumor radioresistance regarding DNA damage responses, cell cycle regulation, hypoxic responses, and antioxidant properties: insight into the development of novel radiosensitizing strategies. Mutat Res, 803–805, 76–81.
14.
IliakisG., MladenovE., and MladenovaV. (2019). Necessities in the processing of DNA double strand breaks and their effects on genomic instability and cancer. Cancers (Basel), 11, 1671–1688.
15.
JungH.I., AhnT., BaeS.H., ChungJ.C., KimH., ChinS., et al. (2015). Astrocyte elevated gene-1 overexpression in hepatocellular carcinoma: an independent prognostic factor. Ann Surg Treat Res, 88, 77–85.
16.
KangD.C., SuZ.Z., SarkarD., EmdadL., VolskyD.J., and FisherP.B. (2005). Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene, 353, 8–15.
17.
LeeS.G., KangD.C., DeSalleR., SarkarD., and FisherP.B. (2013). AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression. Adv Cancer Res, 120, 1–38.
18.
LiP.P., FengL.L., ChenN., GeX.L., LvX., LuK., et al. (2015). Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway. Med Oncol, 32, 21–30.
19.
LiY., GanS., RenL., YuanL., LiuJ., and WangW. (2018). Multifaceted regulation and functions of replication factor C family in human cancers. Am J Cancer Res, 8, 1343–1355.
20.
LiY.H., XuC.L., HeC.J., PuH.H., LiuJ.L., and WangY. (2020). circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC. Mol Carcinog, 59, 141–153.
21.
McBrideW.H., and SchaueD. (2020). Radiation-induced tissue damage and response. J Pathol, 250, 647–655.
22.
McCubreyJ.A., RakusD., GizakA., SteelmanL.S., AbramsS.L., LertpiriyapongK., et al. (2016). Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—diverse effects on cell growth, metabolism and cancer. Biochim Biophys Acta Mol Cell Res, 1863, 2942–2976.
23.
McDuffS.G.R., DietrichJ., AtkinsK.M., OhK.S., LoefflerJ.S., and ShihH.A. (2020). Radiation and chemotherapy for high-risk lower grade gliomas: choosing between temozolomide and PCV. Cancer Med, 9, 3–11.
24.
MorganM.A., and LawrenceT.S. (2015). Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways. Clin Cancer Res, 21, 2898–2904.
25.
OsamaM., MostafaM.N., and AlviM.A. (2020). Astrocyte elevated gene-1 as a novel therapeutic target in malignant gliomas and its interactions with oncogenes and tumor suppressor genes. Brain Res 1747,147034.
26.
PangX., HeG., LuoC., WangY., and ZhangB. (2016). Knockdown ofRad9A enhanced DNA damage induced by trichostatin A in esophageal cancer cells. Tumour Biol, 37, 963–970.
QiuZ., OleinickN.L., and ZhangJ. (2018). ATR/CHK1 inhibitors and cancer therapy. Radiother Oncol, 126, 450–464.
29.
RyuS., BuattiJ.M., MorrisA., KalkanisS.N., RykenT.C., OlsonJ.J., et al. (2014). The role of radiotherapy in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline. J Neurooncol, 118, 489–499.
30.
SakatoM., O'DonnellM., and HingoraniM.M. (2012). A central swivel point in the RFC clamp loader controls PCNA opening and loading on DNA. J Mol Biol, 416, 163–175.
31.
ShiX., and WangX. (2015). The role of MTDH AEG-1 in the progression of cancer. Int J Clin Exp Med, 8, 4795–4807.
32.
SierantM.L., and DaveyS.K. (2018). Identification and characterization of a novel nuclear structure containing members of the homologous recombination and DNA damage response pathways. Cancer Genet, 228–229, 98–109.
33.
SouthgateH.E.D., ChenL., TweddleD.A., and CurtinN.J. (2020). ATR inhibition potentiates PARP inhibitor cytotoxicity in high risk neuroblastoma cell lines by multiple mechanisms. Cancers, 12, 1095–1112.
34.
StuppR., TaillibertS., KannerA., ReadW., SteinbergD.M., LhermitteB., et al. (2017). Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma. JAMA, 318, 2306–2316.
35.
TianX., GengJ., ZhengQ., WangL., HuangP., TongJ., et al. (2020). Single high dose irradiation induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cells through the Ras/Raf/MEK/ERK pathways. Int J Radiat Biol, 96, 740–747.
36.
ToulanyM. (2019). Targeting DNA double-strand break repair pathways to improve radiotherapy response. Genes, 10, 25–45.
37.
WangJ., ChenX., and TongM. (2017). Knockdown of astrocyte elevated gene-1 inhibited cell growth and induced apoptosis and suppressed invasion in ovarian cancer cells. Gene, 616, 8–15.
38.
WangM., XieT., WuY., YinQ., XieS., YaoQ., et al. (2018). Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis. Oncol Lett, 16, 4201–4210.
39.
WangX., CaiL., YeF., LiM., MaL., GengC., et al. (2019a). Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab. Medicine 98,e16937.
40.
WangX.C., YueX., ZhangR.X., LiuT.Y., PanZ.Z., YangM.J., et al. (2019b). Genome-wide RNAi screening identifies RFC4 as a factor that mediates radioresistance in colorectal cancer by facilitating nonhomologous end joining repair. Clin Cancer Res, 25, 4567–4579.
41.
XiongL., WangF., and XieX.Q. (2019). Advanced treatment in high-grade gliomas. J BUON, 24, 424–430.
42.
YuC., LiuY., TanH., LiG., SuZ., RenS., et al. (2014). Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition. Cancer Lett, 343, 258–267.
43.
YuX., WangY., QiuH., SongH., FengD., JiangY., et al. (2018). AEG-1 contributes to metastasis in hypoxia-related ovarian cancer by modulating the HIF-1alpha/NF-kappaB/VEGF pathway. Biomed Res Int 2018,3145689.
44.
ZengZ.M., DuH.Y., XiongL., ZengX.L., ZhangP., CaiJ., et al. (2020). BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest. Life Sci 244,117342.
45.
ZhangY., PengG., WangY., CuiL., WuW., WangL., et al. (2017). Silencing of astrocyte elevated gene-1 inhibits proliferation and migration of melanoma cells and induces apoptosis. Clin Exp Pharmacol Physiol, 44, 815–826.
46.
ZhaoY., MoranM.S., YangQ., LiuQ., YuanC., HongS., et al. (2012). Metadherin regulates radioresistance in cervical cancer cells. Oncol Rep, 27, 1520–1526.
47.
ZhuK., PengY., HuJ., ZhanH., YangL., GaoQ., et al. (2020). Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway. Carcinogenesis, 41, 130–138.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
